Farghaly TA - Search Results

1

Role of bioactive compounds in the treatment of hepatitis: A review.

Roy A, Roy M, Gacem A, Datta S, Zeyaullah M, Muzammil K, Farghaly TA, Abdellattif MH, Yadav KK, Simal-Gandara J. Roy A, et al. Among authors: farghaly ta. Front Pharmacol. 2022 Dec 21;13:1051751. doi: 10.3389/fphar.2022.1051751. eCollection 2022. Front Pharmacol. 2022. PMID: 36618936 Free PMC article. Review.

2

Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.

Hadda TB, Talhi O, Silva ASM, Senol FS, Orhan IE, Rauf A, Mabkhot YN, Bachari K, Warad I, Farghaly TA, Althagafi II, Mubarak MS. Hadda TB, et al. Among authors: farghaly ta. Mini Rev Med Chem. 2018;18(8):711-716. doi: 10.2174/1389557517666170713114039. Mini Rev Med Chem. 2018. PMID: 28714400 Review.

3

Pharmacophores Modeling in Terms of Prediction of Theoretical Physicochemical Properties and Verification by EXPERIMENTAL correlations of Carbacylamidophosphates (CAPh) and Sulfanylamidophosphates (SAPh) Tested as New Carbonic Anhydrase Inhibitors.

Amirkhanov V, Rauf A, Hadda TB, Ovchynnikov V, Trush V, Saleem M, Raza M, Rehman T, Zgou H, Shaheen U, Farghaly TA. Amirkhanov V, et al. Among authors: farghaly ta. Mini Rev Med Chem. 2019;19(12):1015-1027. doi: 10.2174/1389557519666190222172757. Mini Rev Med Chem. 2019. PMID: 30806314

4

Synthesis, tautomeric structures, and antitumor activity of new perimidines.

Farghaly TA, Mahmoud HK. Farghaly TA, et al. Arch Pharm (Weinheim). 2013 May;346(5):392-402. doi: 10.1002/ardp.201200486. Epub 2013 Apr 4. Arch Pharm (Weinheim). 2013. PMID: 23553920

5

Synthesis, anti-HCV, antioxidant, and peroxynitrite inhibitory activity of fused benzosuberone derivatives.

Farghaly TA, Abdel Hafez NA, Ragab EA, Awad HM, Abdalla MM. Farghaly TA, et al. Eur J Med Chem. 2010 Feb;45(2):492-500. doi: 10.1016/j.ejmech.2009.10.033. Epub 2009 Oct 29. Eur J Med Chem. 2010. PMID: 19913334

6

Antimicrobial, antitumor and 5α-reductase inhibitor activities of some hydrazonoyl substituted pyrimidinones.

Edrees MM, Farghaly TA, El-Hag FA, Abdalla MM. Edrees MM, et al. Among authors: farghaly ta. Eur J Med Chem. 2010 Dec;45(12):5702-7. doi: 10.1016/j.ejmech.2010.09.026. Epub 2010 Sep 17. Eur J Med Chem. 2010. PMID: 20933305

7

New Coumarin Derivatives as Potent Selective COX-2 Inhibitors: Synthesis, Anti-Inflammatory, QSAR, and Molecular Modeling Studies.

Dawood DH, Batran RZ, Farghaly TA, Khedr MA, Abdulla MM. Dawood DH, et al. Among authors: farghaly ta. Arch Pharm (Weinheim). 2015 Dec;348(12):875-88. doi: 10.1002/ardp.201500274. Epub 2015 Oct 13. Arch Pharm (Weinheim). 2015. PMID: 26462142

8

Design and synthesis of novel complexes containing N-phenyl-1H-pyrazole moiety: Ni complex as potential antifungal and antiproliferative compound.

El-Gamel NE, Farghaly TA. El-Gamel NE, et al. Among authors: farghaly ta. Spectrochim Acta A Mol Biomol Spectrosc. 2013 Nov;115:469-75. doi: 10.1016/j.saa.2013.06.067. Epub 2013 Jun 29. Spectrochim Acta A Mol Biomol Spectrosc. 2013. PMID: 23871973

9

Synthesis of pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5-ones as potential antimicrobial agents.

Farghaly TA, Hassaneen HM. Farghaly TA, et al. Arch Pharm Res. 2013 May;36(5):564-72. doi: 10.1007/s12272-013-0045-2. Epub 2013 Feb 28. Arch Pharm Res. 2013. PMID: 23446650

10

A Facile One-pot Synthesis and Antimicrobial Activity of Pyrido [2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5-ones.

Farghaly TA, Riyadh SM, Abdallah MA, Ramadan MA. Farghaly TA, et al. Acta Chim Slov. 2011 Mar;58(1):87-94. Acta Chim Slov. 2011. PMID: 24061948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page